Revvity RVTY
NYSE RVTY
$150.76 -1.88 (-1.23%)
As of: Oct 19, 2026 · 3:59 PM EDT

Revvity (RVTY) Gains from Sales and Divestitures (2009 - 2026)

Updated

Revvity's Gains from Sales and Divestitures was $5.07 million in Q1 2026.

Analysis

Revvity (RVTY) Gains from Sales and Divestitures (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.93 Bn 230.96 Bn 4.88 Bn
2 Abbott Laboratories 181.29 Bn 151.72 Bn 7.27 Bn
3 Danaher 158.18 Bn 141.99 Bn 3.61 Bn
4 Intuitive Surgical 153.47 Bn 132.89 Bn 1.96 Bn
5 Medtronic 118.97 Bn 84.22 Bn 6.34 Bn
6 Stryker 114.72 Bn 100.84 Bn 4.50 Bn
7 Boston Scientific 66.18 Bn 60.95 Bn 3.85 Bn
8 Becton Dickinson 52.49 Bn 49.64 Bn 2.32 Bn
9 Edwards Lifesciences 50.32 Bn 34.33 Bn 1.35 Bn
10 Revvity 16.87 Bn 13.14 Bn 416.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 5, 2026 5.07 Mn
Dec 28, 2014 -108,000.00
Dec 29, 2013 -3.38 Mn
Sep 30, 2012 1.72 Mn
Jan 1, 2012 -29.06 Mn
Oct 3, 2010 -247,000.00
Jul 4, 2010 2.85 Mn
Jan 3, 2010 3.56 Mn
Oct 4, 2009 -1.57 Mn
Jul 5, 2009 -399,000.00
API Access

Revvity Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=RVTY&period=max&api_key=YOUR_API_KEY